Breast Cancer

Meet the investigator: Donald W. Northfelt, M.D.

Donald W. Northfelt, M.D., an oncologist and breast cancer researcher at Mayo Clinic in Phoenix, Arizona, talks about his research, his mentors and promoting equity in clinical trials.

Breast cancer risk score buoys preventive medication use

Studies show that the risk of breast cancer can be reduced by half through the use of a five-year course of tamoxifen or raloxifene and[...]

Study backs oxybutynin for Hot Flashes in Breast Cancer Survivors

Research led by Mayo Clinic oncologists Roberto A. Leon Ferre, M.D., and Charles L. Loprinzi, M.D., has found that the drug oxybutynin helps reduce the[...]

Less-invasive mastectomy safe option for more breast cancer patients

A less-invasive nipple-sparing mastectomy that leaves the surface of the breast intact has become a safe option for more patients, including those whose breast cancer[...]

Vaccine study for HER2-positive breast cancer moves forward

Treating breast cancer has long involved addressing two problems: the elimination of cancer cells from the tumor and potential disease recurrence. The key may be[...]

Meet the investigator: Keith L. Knutson, Ph.D.

Keith L. Knutson, Ph.D., an immunologist at Mayo Clinic's campus in Florida and a professor in the Mayo Clinic College of Medicine and Science, discusses his research on the immunology and immunotherapy of breast cancer and ovarian cancer.